SCHEMBL30973501

SCHEMBL30973501

Cc1cc2occc2c(O)c1-c1cc2scc(C3=CCOCC3)c2nn1

nearest known ligand 0.31

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
EED O75530 1/20 0.31
RBBP4 Q09028 1/20 0.31
SUZ12 Q15022 1/20 0.31
EZH2 Q15910 1/20 0.31
PIK3CD O00329 1/20 0.30
PIK3CA P42336 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30973532 0.85 EED (0.32) EEDRBBP4SUZ12EZH2
SCHEMBL30973433 0.79 MEN1 (0.33)
SCHEMBL30973399 0.78
SCHEMBL30973239 0.78 MAOA (0.36)
SCHEMBL30973511 0.77
SCHEMBL30973324 0.68 MAOB (0.35)
SCHEMBL30973284 0.62 IL1B (0.37)
SCHEMBL30973253 0.58 IL1B (0.32)
SCHEMBL30973308 0.58 MAPT (0.33)
SCHEMBL15518914 0.58 PDE3B (0.39) PIK3CDPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642784-A1 HETEROCYCLIC AND HETEROARYL COMPOUNDS AS INHIBITORS OF NLRP3 PTC Therapeutics, Inc. (US) 2025-11-05 EP disclosed
WO-2024145623-A1 HETEROCYCLIC AND HETEROARYL COMPOUNDS AS INHIBITORS OF NLRP3 PTC THERAPEUTICS, INC. (US) 2024-07-04 WO disclosed